Website stats for Biontech - biontech.de
Ushering in a new era of cancer medicine "We founded BioNTech to advance and develop key technologies and bring together the right people to realize our vision for the future of cancer medicine" SCIENCE
It has a alexa rank of #116,995 in the world. It is a domain having .de extension. It is estimated worth of $ 106,800.00 and have a daily income of around $ 178.00. As no active threats were reported recently, biontech.de is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 14,239 |
| Daily Pageviews: | 71,195 |
Estimated Valuation
| Income Per Day: | $ 178.00 |
| Estimated Worth: | $ 106,800.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 116,995 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
57 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
23.185.0.1
Hosted Country:
US
Location Latitude:
37.792Location Longitude:
-122.407Search Engine Results For biontech.de
BioNTech: We aspire to individualize cancer medicine
At BioNTech we believe that every cancer patient's treatment should be individualized. Our vision is to provide patient-specific immunotherapies worldwide.
COVID-19 | BioNTech
Our mRNA-based approach for a COVID -19 vaccine. SARS-CoV-2 is a ...
Pipeline | BioNTech
BioNTech advances a deep and broad portfolio of product candidates in ...
Careers | BioNTech
BioNTech was founded in Mainz, Germany and we are rooted in Germany with a ...
Investors & Media | BioNTech
The Investor Relations website contains information about BioNTech's ...
Leadership | BioNTech
Leadership. MANAGEMENT; SUPERVISORY BOARD; Scientific Advisory Board ...
Our vision | BioNTech
We are a next generation immunotherapy powerhouse pioneering individualized ...
Services | BioNTech
BioNTech Innovative Manufacturing Service GmbH (BIMFS) is a fully-owned ...
BioNTech - Wikipedia
BioNTech SE is a German biotechnology company based in Mainz that develops and ... Number of employees. Increase 1,323 (2019). Website, biontech.de.
BioNTech SE | LinkedIn
Website: https://biontech.de/. Industries: Biotechnology. Company size: 1001- 5000 employees. Headquarters: Mainz, Rhineland-Palatinate. Type: Privately Held.
biontech.de Reviews | Read Customer Service Reviews of biontech.de
The mRNA vaccines from BioNTech/Pfizer contain polyethylene glycol (PEG). 70 % of people develop antibodies against this substance - this means that many ...
BioNTech SE (BNTX) Stock Price, News, Quote & History - Yahoo ...
Company Profile. An der Goldgrube 12. Mainz 55131. Germany 49 6131 9084 0 · http://www.biontech.de. Sector(s): Healthcare Industry: Biotechnology Full Time ...
BioNTech SE (@BioNTech_Group) | Twitter
The latest Tweets from BioNTech SE (@BioNTech_Group). Our vision is to harness the power of the ... Mainz, Germany · biontech.de. Joined November 2018 ...
22UA:Frankfurt Stock Quote - BioNTech SE - Bloomberg Markets
Stock analysis for BioNTech SE (22UA:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
BioNTech - Pagan Research! Online B2B Lead Database ...
BioNTech AG is Europe's largest privately held biopharmaceutical company ... Employee: Ugur Sahin; Title: Founder and CEO; Email: [email protected] ...
BioNTech SE Announcements | BioNTech SE ... - Investegate
18 hours ago ... Participants may also access the press conference, including the video webcast, on https://biontech.de/ under "Events & Presentations" in the ...
BioNTech company information, funding & investors | Dealroom.co
Recent News about BioNTech. Edit · Vacuna de Pfizer podría ser autorizada a partir de la próxima semana en Chile.
BioNTech SE - ADR (BNTX : NASDAQ) Stock Price & News - Google ...
Pfizer, BioNTech Covid Vaccine Receives European Backing ... E.U. committee recommends authorization of BioNTech and Pfizer's coronavirus ... biontech.de.
Pfizer and BioNTech Announce Vaccine Candidate Against COVID ...
9 Nov 2020 ... For more information, please visit www.BioNTech.de . BioNTech Forward-looking statements. This press release contains “forward-looking ...
Biopharma leaders unite to stand with science - AstraZeneca
8 Sep 2020 ... For more information, please visit https://biontech.de/. About GlaxoSmithKline. GSK is a science-led global healthcare company with a special ...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 4 | H2 Headings: | 13 |
| H3 Headings: | 1 | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 4 | Total Images: | 28 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| cancer medicine | 8 | 1.826 % | No |
| Our DNA | 4 | 0.913 % | No |
| individualize cancer | 4 | 0.913 % | No |
| Investors Media | 3 | 0.685 % | No |
| Our vision | 3 | 0.685 % | No |
| for patients | 3 | 0.685 % | No |
| Media Careers | 3 | 0.685 % | No |
| our vision | 3 | 0.685 % | No |
| represents a | 2 | 0.457 % | No |
| a disruptive | 2 | 0.457 % | No |
| For Patients | 2 | 0.457 % | No |
| we enable our | 2 | 0.457 % | No |
| services How | 2 | 0.457 % | No |
| How we enable | 2 | 0.457 % | No |
| vision Why | 2 | 0.457 % | No |
| Why mRNA | 2 | 0.457 % | No |
| new drug | 2 | 0.457 % | No |
| antibody discovery | 2 | 0.457 % | No |
| discovery engines | 2 | 0.457 % | No |
| engines Manufacturing | 2 | 0.457 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| disruptive new drug class | 2 | 0.457 % | No |
| new drug class Beyond | 2 | 0.457 % | No |
| drug class Beyond mRNA | 2 | 0.457 % | No |
| a disruptive new drug | 2 | 0.457 % | No |
| represents a disruptive new | 2 | 0.457 % | No |
| vision Why mRNA represents | 2 | 0.457 % | No |
| Why mRNA represents a | 2 | 0.457 % | No |
| mRNA represents a disruptive | 2 | 0.457 % | No |
| class Beyond mRNA our | 2 | 0.457 % | No |
| Beyond mRNA our antibody | 2 | 0.457 % | No |
| Manufacturing our own therapeutics | 2 | 0.457 % | No |
| our own therapeutics Explore | 2 | 0.457 % | No |
| own therapeutics Explore our | 2 | 0.457 % | No |
| engines Manufacturing our own | 2 | 0.457 % | No |
| discovery engines Manufacturing our | 2 | 0.457 % | No |
| mRNA our antibody discovery | 2 | 0.457 % | No |
| our antibody discovery engines | 2 | 0.457 % | No |
| antibody discovery engines Manufacturing | 2 | 0.457 % | No |
| our vision Why mRNA | 2 | 0.457 % | No |
| we enable our vision Why | 2 | 0.457 % | No |
Websites Hosted on Same IP (i.e. 23.185.0.1)
Homepage - Operation Blessing
Operation Blessing is a nonprofit, humanitarian organization dedicated to partnering with YOU to demonstrate God’s love by alleviating human suffering in the U.S. and around the...
2,102,501 
$ 720.00
World Vision Philippines | Sponsor A Child | Support A Community
We are a global humanitarian organization devoted to improving the lives of children, their families, and communities to overcome poverty.
1,090,856 $ 1,200.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Connection: keep-alive
Cache-Control: must-revalidate, no-cache, private
Content-Encoding: gzip
Content-Language: en
Content-Type: text/html; charset=UTF-8
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Link:
Server: nginx
Strict-Transport-Security: max-age=300
X-Content-Type-Options: nosniff
X-Drupal-Cache: HIT
X-Drupal-Dynamic-Cache: HIT
X-Frame-Options: SAMEORIGIN
X-Generator: Drupal 8 (https://www.drupal.org)
X-Pantheon-Styx-Hostname: styx-fe1fe2-c-745dcdf998-tcdcb
X-Styx-Req-Id: 14659cff-3875-11eb-8695-1ef69e2a5418
X-Ua-Compatible: IE=edge
Date: Mon, 07 Dec 2020 10:15:06 GMT
X-Served-By: cache-ams21054-AMS, cache-fra19136-FRA
X-Cache: MISS, MISS
X-Cache-Hits: 0, 0
X-Timer: S1607336107.939386,VS0,VE28
Vary: Accept-Encoding, Cookie, Cookie
Age: 0
Accept-Ranges: bytes
Via: 1.1 varnish, 1.1 varnish
transfer-encoding: chunked
Domain Information
| Domain Registrar: |
DENIC eG
|
|---|---|
| Last Modified: | 2020-02-13 4 years 7 months 2 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns01.versatel.de | |
212.7.128.162 |  Germany |
| ns02.versatel.de | |
212.7.128.165 | Germany |
| ns04.versatel.de | |
62.214.96.228 | Germany |
Full WHOIS Lookup
%
% Terms and Conditions of
Use
%
% The above data may only be used within the scope of
technical or
% administrative necessities of Internet operation or
to remedy legal
% problems.
% The use for other purposes, in
particular for advertising, is not permitted.
%
% The DENIC
whois service on port 43 doesn't disclose any information
concerning
% the domain holder, general request and abuse
contact.
% This information can be obtained through use of our
web-based whois service
% available at the DENIC website:
%
http://www.denic.de/en/domains/whois-service/web-whois.html
%
%
Domain: biontech.de
Nserver:
ns01.versatel.de
Nserver: ns02.versatel.de
Nserver:
ns04.versatel.de
Status: connect
Changed:
2020-02-13T11:37:59+01:00
Similarly Ranked Websites
Pixum Fotobuch & Fotokalender in Testsieger-Qualität
Fotobücher - Testsieger bei Stiftung Warentest -, Leinwände, Poster u.v.m. beim Fotoservice Pixum gestalten. Pixum Fotowelt Software kostenlos herunterladen - auch als App.
116,999 $ 106,800.00
Szubin - Pod dobrymi skrzydłami - Szubin
Oficjalny serwis gminy i miasta Szubin. Pod dobrymi skrzydłami.
116,999 $ 106,800.00
KPSS Cafe - KPSS Haber ve Hazırlık Portalı
KPSS Cafe'de, son dakika KPSS haberleri, KPSS testleri, ilanlar, sorular, videolu derslerle KPSS ile ilgili ulaşmak istediğiniz tüm haberleri bulacaksınız.
117,003 $ 106,800.00